138
Views
40
CrossRef citations to date
0
Altmetric
Review

Biological therapy of traditional therapy-resistant adult-onset Still’s disease: an evidence-based review

, , , &
Pages 167-171 | Published online: 24 Jan 2018

References

  • BywatersEGStill’s disease in the adultAnn Rheum Dis19713021211335315135
  • Al-HomoodIABiologic treatments for adult-onset Still’s diseaseRheumatology (Oxford)2014531323823864171
  • CastanedaSBlancoRGonzalez-GayMAAdult-onset still’s disease: advances in the treatmentBest Pract Res Clin Rheumatol201630222223827886796
  • KadavathSEfthimiouPAdult-onset Still’s disease-pathogenesis, clinical manifestations, and new treatment optionsAnn Med201547161425613167
  • Gerfaud-ValentinMMaucort-BoulchDHotAAdult-onset still disease: manifestations, treatment, outcome, and prognostic factors in 57 patientsMedicine (Baltimore)2014932919924646465
  • Gerfaud-ValentinMJamillouxYIwazJSevePAdult-onset Still’s diseaseAutoimmun Rev201413770872224657513
  • de BoyssonHFevrierJNicolleAAuzaryCGeffrayLTocilizumab in the treatment of the adult-onset Still’s disease: current clinical evidenceClin Rheumatol201332114114723108887
  • JamillouxYGerfaud-ValentinMHenryTSevePTreatment of adult-onset Still’s disease: a reviewTher Clin Risk Manag201511334325653531
  • YamaguchiMOhtaATsunematsuTPreliminary criteria for classification of adult Still’s diseaseJ Rheumatol19921934244301578458
  • FautrelBZingEGolmardJLProposal for a new set of classification criteria for adult-onset still diseaseMedicine (Baltimore)200281319420011997716
  • ChoiJHSuhCHLeeYMSerum cytokine profiles in patients with adult onset Still’s diseaseJ Rheumatol200330112422242714677188
  • FitzgeraldAALeclercqSAYanAHomikJEDinarelloCARapid responses to anakinra in patients with refractory adult-onset Still’s diseaseArthritis Rheum20055261794180315934079
  • CavagnaLCaporaliREpisOBobbio-PallaviciniFMontecuccoCInfliximab in the treatment of adult Still’s disease refractory to conventional therapyClin Exp Rheumatol200119332933211407090
  • PouchotJArletJBBiological treatment in adult-onset Still’s diseaseBest Pract Res Clin Rheumatol201226447748723040362
  • OstrowskiRATehraniRKadanoffRRefractory adult-onset still disease successfully treated with abataceptJ Clin Rheumatol201117631531721869709
  • QuartuccioLMasetMDe VitaSEfficacy of abatacept in a refractory case of adult-onset Still’s diseaseClin Exp Rheumatol201028226526720483052
  • SouabniLDridiLBen AbdelghaniKPossible macrophage activation syndrome following initiation of adalimumab in a patient with adult-onset Still’s diseasePan Afr Med J2014179425018831
  • AhmedOBrahmaniaMAlsahafiMAlkhowaiterSErbSAnakinra Hepatotoxicity in a patient with adult-onset still’s diseaseACG Case Rep J20152317317426157954
  • Fischer-BetzRSpeckerCSchneiderMSuccessful outcome of two pregnancies in patients with adult-onset Still’s disease treated with IL-1 receptor antagonist (anakinra)Clin Exp Rheumatol20112961021102322153586
  • Lo GulloACarusoAPipitoneNMacchioniPPazzolaGSalvaraniCCanakinumab in a case of adult onset still’s disease: efficacy only on systemic manifestationsJoint Bone Spine201481437637724462130
  • BarsottiSNeriRIacopettiVSuccessful treatment of refractory adult-onset still disease with canakinumab: a case reportJ Clin Rheumatol201420212124561423
  • AikawaNERibeiroACSaadCGIs anti-TNF switching in refractory Still’s disease safe and effective?Clin Rheumatol20113081129113421465126
  • NordstromDKnightALuukkainenRBeneficial effect of interleukin 1 inhibition with anakinra in adult-onset Still’s disease. An open, ran-domized, multicenter studyJ Rheumatol201239102008201122859346
  • TsuchidaYSumitomoSShodaHKuboKFujioKYamamotoKMacrophage activation syndrome associated with tocilizumab treatment in adult-onset Still’s diseaseMod Rheumatol201612
  • PuechalXDeBandtMBerthelotJMTocilizumab in refractory adult Still’s diseaseArthritis Care Res (Hoboken)201163115515920740616
  • PetrynaOCushJJEfthimiouPIL-1 Trap rilonacept in refractory adult onset Still’s diseaseAnn Rheum Dis201271122056205722679302
  • WatanabeESugawaraHYamashitaTIshiiAOdaATeraiCSuccessful tocilizumab therapy for macrophage activation syndrome associated with adult-onset still’s disease: a case-based reviewCase Rep Med20162016565632027688774
  • DebiaisSMaillotFLucaLBuretJFautrelBRenardJPEfficacy of anakinra in a case of refractory Still diseaseJ Clin Rheumatol200814635735819033875
  • AlyLIking-KonertCQuaasABentenDSubacute liver failure following anakinra treatment for adult-onset Still diseaseJ Rheumatol201340101775177724085761
  • AgarwalSMoodleyJAjani GoelGTheilKSMahmoodSSLangRSA rare trigger for macrophage activation syndromeRheumatol Int201131340540719834709
  • MehtaBMHashkesPJAveryRDealCLA 21-year-old man with Still’s disease with fever, rash, and pancytopeniaArthritis Care Res (Hoboken)201062457557920391515
  • LequerreTQuartierPRoselliniDInterleukin-1 receptor antagonist (anakinra) treatment in patients with systemic-onset juvenile idiopathic arthritis or adult onset Still disease: preliminary experience in FranceAnn Rheum Dis200867330230817947302
  • SchulertGSGromAAPathogenesis of macrophage activation syndrome and potential for cytokine-directed therapiesAnnu Rev Med20156614515925386930
  • BergerCTRecherMSteinerUHauserTMA patient’s wish: anakinra in pregnancyAnn Rheum Dis200968111794179519822718
  • MoulisGSaillerLAstudilloLPugnetGArletPMay anakinra be used earlier in adult onset Still disease?Clin Rheumatol201029101199120020428907